Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 391-400 of 1760 for

Edit search filters
  1. Enhancing Facial Nerve Neuroprotection and Regeneration Through Omega-3 Supplementation Following Vestibular Schwannoma Resection

    Rochester, MN

  2. Intratumoral Extracellular Metabolic Impact Of DFMO And AMXT 1501 In Patients With Diffuse Or High Grade Glioma

    Rochester, MN

  3. Ph. 1, Evaluation Of Safety, Tolerability, PK, Anti-tumor Activity Of STP707 IV In Subjects With Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study To Evaluate Gemcitabine In Patients Undergoing Radical Nephroureterectomy For Upper Tract Urothelial Carcinoma

    Jacksonville, FL, Rochester, MN

  5. Study Of Pembrolizumab/Vibostolimab Coformulation (MK-7684A) In Combination With Chemotherapy Versus Pembrolizumab Plus Chemotherapy In Participants With Metastatic Non-Small Cell Lung Cancer (MK-7684A-007/KEYVIBE-007)

    Jacksonville, FL, Rochester, MN

  6. A Study To Evaluate ELU001 In Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Intravital Microscopy (IVM) In Patients With Peritoneal Carcinomatosis (PC)

    Jacksonville, FL

  8. Alternate Doses And Dosing Schedules Of Belantamab Mafodotin For The Treatment Of Triple-Class Recurrent And/or Refractory Multiple Myeloma

    Jacksonville, FL

  9. A Study To Compare Treatment With The Drug Selumetinib Alone Versus Selumetinib And Vinblastine In Patients With Recurrent Or Progressive Low-Grade Glioma

    Rochester, MN

  10. Improving Adolescent And Young Adult Self-Reported Data In ECOG-ACRIN Trials

    Rochester, MN

.

Mayo Clinic Footer